• A group 3 medulloblastoma stem cell program is maintained by OTX2-mediated alternative splicing
• A human fetal cerebellar map of the late second trimester reveals developmental molecular characteristics and abnormality in trisomy 21
• A novel indole derivative, 2-{3-[1-(benzylsulfonyl)piperidin-4-yl]-2-methyl-1H-indol-1-yl}-1-(pyrrolidin-1-yl)ethenone, suppresses hedgehog signaling and drug-resistant tumor growth
• A Radiomic Approach for Evaluating Intra-Subgroup Heterogeneity in SHH and Group 4 Pediatric Medulloblastoma: A Preliminary Multi-Institutional Study
• A simple and scalable zebrafish model of Sonic hedgehog medulloblastoma
• A single-cell transcriptomic map of the developing Atoh1 lineage identifies neural fate decisions and neuronal diversity in the hindbrain
• Advancing presurgical non-invasive molecular subgroup prediction in medulloblastoma using artificial intelligence and MRI signatures
• An Adult Case of Medulloblastoma with Multiple Lung Metastatic Lesions-Case Report and Literature Review
• An update on central nervous system tumors in germline replication-repair deficiency syndromes
• ASL Perfusion Lightbulb Sign: An Imaging Biomarker of Pediatric Posterior Fossa Hemangioblastoma
• Bioinformatic Analysis of Gene Expression Related to Sialic Acid Biosynthesis in Patients With Medulloblastoma
• Cdc14B/Cyclin B1 signaling modulates the pathogenesis of sonic hedgehog subtype medulloblastoma
• Cervical Lymph Node Metastasis From Medulloblastoma in a Young Adult: Case Report and Literature Review
• CircRNA and lncRNA-associated competing endogenous RNA networks in medulloblastoma: a scoping review
• Clinicopathological characteristics of the CD8(+) T lymphocytes infiltration and its mechanism in distinct molecular subtype of medulloblastoma
• CSF biomarkers of neurotoxicity in childhood cancer survivors after cranial radiotherapy or surgery
• Deciphering Natural Killer Cell Cytotoxicity Against Medulloblastoma in vitro and in vivo: Implications for Immunotherapy
• Deep learning models for predicting the survival of patients with medulloblastoma based on a surveillance, epidemiology, and end results analysis
• Distribution of EGFR fusions in 35,023 Chinese patients with solid tumors-the frequency, fusion partners and clinical outcome
• Doing more with less: surgical results of pediatric posterior fossa tumors from a single center in Latin America
• Dynamics and predictors of hematologic toxicity during cranio-spinal irradiation
• Early rhombic lip Protogenin(+ve) stem cells in a human-specific neurovascular niche initiate and maintain group 3 medulloblastoma
• Effective re-induction regimen for children with recurrent medulloblastoma
• ENTPD1 (CD39) and NT5E (CD73) expression in human medulloblastoma: an in silico analysis
• Epidemiological trends and factors associated with survival in patients with medulloblastoma: A 45-year population-based retrospective study
• Evolution of Proton Radiotherapy Brainstem Constraints on the Pediatric Proton/Photon Consortium Registry
• Extracranial metastatic oligodendroglioma with molecular progression, case presentation
• Fourth Ventricular Rosai-Dorfman Disease Mimicking Intraventricular Tumor in Young Adult: A Rare Case Report
• G-quadruplexes are a source of vulnerability in BRCA2 deficient granule cell progenitors and medulloblastoma
• Generation of two isogenic patient-derived human-induced pluripotent stem cell clones with 6q27 deletion
• Genome-wide CRISPR-Cas9 knockout screens identify DNMT1 as a druggable dependency in sonic hedgehog medulloblastoma
• Germline PTCH1: c.361_362insAlu alteration identified by comprehensive exome and RNA sequencing in a patient with Gorlin syndrome
• Heterogeneity of fibroblast activation protein expression in the microenvironment of an intracranial tumor cohort: head-to-head comparison of gallium-68 FAP inhibitor-04 (⁶⁸Ga-FAPi-04) and fluoride-18 fluoroethyl-L-tyrosine (<sup
• HIF-1 inactivation empowers HIF-2 to drive hypoxia adaptation in aggressive forms of medulloblastoma
• High-throughput neural stem cell-based drug screening identifies S6K1 inhibition as a selective vulnerability in SHH-medulloblastoma
• Identification and validation of miRNA-target genes network in pediatric brain tumors
• Identification of a prognosis-related phagocytosis regulator gene signature in medulloblastoma
• Identification of tumor rejection antigens and the immunologic landscape of medulloblastoma
• Immunotherapy, prognostic, and tumor biomarker based on pancancer analysis, SMARCD3
• In vivo modeling recapitulates radiotherapy delivery and late-effect profile for childhood medulloblastoma
• Inhibition of STAT3: A promising approach to enhancing the efficacy of chemotherapy in medulloblastoma
• Insights into brain tumor diagnosis: exploring <em>in situ</em> hybridization techniques
• Intracerebellar administration of the chemokine Cxcl3 reduces the volume of medulloblastoma lesions at an advanced stage by promoting the migration and differentiation of preneoplastic precursor cells
• Leading medulloblastoma to a differentiation end
• Letter to the editor "Neurosurgical short-term outcomes for pediatric medulloblastoma patients and molecular correlations: a 10-year single-centre observation cohort study"
• Machine Learning Analysis in Diffusion Kurtosis Imaging for Discriminating Pediatric Posterior Fossa Tumors: A Repeatability and Accuracy Pilot Study
• Maintaining Survival While Improving Quality of Life: An Advanced Practitioner-Led Pilot Feasibility Study to Reduce Radiation Dose in Children With Brain Tumors
• Mechanistic insights into medulloblastoma relapse
• Medulloblastoma in children with Fanconi anemia: Association with FA-D1/FA-N, SHH type and poor survival independent of treatment strategies
• Medulloblastoma Spatial Transcriptomics Reveals Tumor Microenvironment Heterogeneity with High-Density Progenitor Cell Regions Correlating with High-Risk Disease
• Medulloblastoma subgrouping at first sight
• Medulloblastomas Initiated by Homologous Recombination Defects in Mice
• Medulloblastomas with ELP1 pathogenic variants: A weakly penetrant syndrome with a restricted spectrum in a limited age window
• Molecular Subgrouping Based on Immunohistochemistry in Medulloblastoma: a Single-Center Experience
• Mosaic SUFU mutation associated with a mild phenotype of multiple hereditary infundibulocystic basal cell carcinoma syndrome
• Multiomic profiling of medulloblastoma reveals subtype-specific targetable alterations at the proteome and N-glycan level
• Neurocognitive outcomes and functional independence in adult survivors of childhood medulloblastoma diagnosed over three decades
• Neurosurgical short-term outcomes for pediatric medulloblastoma patients and molecular correlations: a 10-year single-center observation cohort study
• Nn-Unet-based Segmentation of Tumor Subcompartments in Pediatric Medulloblastoma Using Multiparametric MRI: A Multi-institutional Study
• Olivary Hypertrophy Induced Palatal Myoclonus in a Treated Case of Medulloblastoma
• Overcoming Treatment Resistance in Medulloblastoma: Underlying Mechanisms and Potential Strategies
• Pediatric Tumors as Disorders of Development: The Case for In Vitro Modeling Based on Human Stem Cells
• Pediatric WNT medulloblastoma predisposition in intraoperative blood loss: a retrospective observational cohort study
• Peritoneal metastasis of a cerebellar medulloblastoma through a ventriculoperitoneal shunt: A case report
• Persistent hypoxemia in a child with medulloblastoma following a third autologous stem cell transplant
• Phase I and pharmacodynamic study of arsenic trioxide plus radiotherapy in patients with newly diagnosed glioblastoma
• PP2A phosphatase regulatory subunit PPP2R3C is a new positive regulator of the hedgehog signaling pathway
• PRDM6 promotes medulloblastoma by repressing chromatin accessibility and altering gene expression
• Predicting response to chemotherapy in brain tumor patients based on MRI features
• Prostaglandin F2 Receptor Negative Regulator (PTGFRN) Expression Correlates With a Metastatic-like Phenotype in Epidermoid Carcinoma, Pediatric Medulloblastoma, and Mesothelioma
• Proteomics Analysis of Proteotoxic Stress Response in In-Vitro Human Neuronal Models
• Radiation-induced cavernoma in pediatric CNS tumors: a systematic review and treatment paradigm
• Radiation-Induced Low-Grade Glioma following Radiotherapy for Squamous Cell Carcinoma of the Scalp: Case Report and Literature Review
• Radiotherapy for Recurrent Medulloblastoma in Children and Adolescents: Survival after Re-Irradiation and First-Time Irradiation
• Rational Design of Novel Allosteric EYA2 Inhibitors as Potential Therapeutics for Multiple Brain Cancers
• Regulation of primary cilia disassembly through HUWE1-mediated TTBK2 degradation plays a crucial role in cerebellar development and medulloblastoma growth
• Relative Biological Effectiveness of Carbon Ion Beams for Induction of Medulloblastoma with Radiation-specific Chromosome 13 Deletion in Ptch1+/- Mice
• REST-dependent downregulation of von Hippel-Lindau tumor suppressor promotes autophagy in SHH-medulloblastoma
• Rosettes and pseudorosettes in veterinary neuropathology
• Secondary cancer risk assessment in healthy organs following craniospinal irradiation
• Single-Cell Chromatin Accessibility Analysis Reveals Subgroup-Specific TF-NTR Regulatory Circuits in Medulloblastoma
• SOX2 represses c-MYC transcription by altering the co-activator landscape of the c-MYC super-enhancer and promoter regions
• Survival-Related Genes on Chromosomes 6 and 17 in Medulloblastoma
• Synergy of retinoic acid and BH3 mimetics in MYC(N)-driven embryonal nervous system tumours
• Targeting axonal guidance dependencies in glioblastoma with ROBO1 CAR T cells
• The cochlear dose and the age at radiotherapy predict severe hearing loss after passive scattering proton therapy and cisplatin in children with medulloblastoma
• The dark side of T2: central nervous system lesions with low signal intensity on T2-weighted imaging
• The Pattern of Anemia in Pediatric Solid Tumors Prior to and after Chemotherapy- A Retrospective Cohort Study
• The Role of CyberKnife Stereotactic Radiosurgery in Recurrent Cranial Medulloblastomas across Pediatric and Adult Populations
• The Role of the RNA Helicase DDX3X in Medulloblastoma Progression
• Thyroid hormone suppresses medulloblastoma progression through promoting terminal differentiation of tumor cells
• Toxoplasma gondii infection supports the infiltration of T cells into brain tumors
• Treatment of Medulloblastoma in the Adolescent and Young Adult Population: A Systematic Review
• Triptolide and its pro-drug Minnelide target high-risk MYC amplified medulloblastoma in preclinical models
• Triptolide and its prodrug Minnelide target high-risk MYC-amplified medulloblastoma in preclinical models
• Unexpected Cerebral Hyperperfusion after Transient Hypoperfusion Associated with Stroke-like Migraine Attacks after Radiation Therapy Syndrome
• Unusual delayed postradiation vasculopathy mimicking tumour in an early adolescent with a remote history of metastatic medulloblastoma
• Using diffusion MRI to understand white matter damage and the link between brain microstructure and cognitive deficits in paediatric medulloblastoma patients
• Utility of OLIG2 immunostaining in pediatric brain tumors with embryonal morphology
• VISTA Emerges as a Promising Target against Immune Evasion Mechanisms in Medulloblastoma